z-logo
open-access-imgOpen Access
Letter by Koh Regarding Article, “Empagliflozin and Clinical Outcomes in Patients With Type 2 Diabetes Mellitus, Established Cardiovascular Disease, and Chronic Kidney Disease”
Author(s) -
Kwang Kon Koh
Publication year - 2018
Publication title -
circulation
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 7.795
H-Index - 607
eISSN - 1524-4539
pISSN - 0009-7322
DOI - 10.1161/circulationaha.118.033867
Subject(s) - empagliflozin , medicine , renal function , diabetes mellitus , type 2 diabetes mellitus , kidney disease , type 2 diabetes , creatinine , population , dapagliflozin , canagliflozin , endocrinology , urology , environmental health

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom